Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity
Author(s) -
Mehdi Tafti,
Gert Jan Lammers,
Yves Dauvilliers,
Sebastiaan Overeem,
Geert Mayer,
Jacek Nowak,
Corinne Pfister,
Valérie Dubois,
JeanFrançois Eliaou,
Hans-Peter Eberhard,
Roland Liblau,
Aleksandra Wierzbicka,
Peter Geisler,
Claudio L. Bassetti,
Johannes Mathis,
Michel Lecendreux,
Ramin Khatami,
Raphaël Heinzer,
José HabaRubio,
Eva Feketeová,
Christian R. Baumann,
Zoltán Kutalik,
J.-M. Tiercy
Publication year - 2016
Publication title -
sleep
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.222
H-Index - 207
eISSN - 1550-9109
pISSN - 0161-8105
DOI - 10.5665/sleep.5532
Subject(s) - narcolepsy , cataplexy , human leukocyte antigen , allele , cd8 , immunology , genetics , genotype , biology , immune system , antigen , gene , neuroscience , neurology
Narcolepsy with cataplexy is tightly associated with the HLA class II allele DQB1*06:02. Evidence indicates a complex contribution of HLA class II genes to narcolepsy susceptibility with a recent independent association with HLA-DPB1. The cause of narcolepsy is supposed be an autoimmune attack against hypocretin-producing neurons. Despite the strong association with HLA class II, there is no evidence for CD4+ T-cell-mediated mechanism in narcolepsy. Since neurons express class I and not class II molecules, the final effector immune cells involved might include class I-restricted CD8+ T-cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom